EVRAN SEDAT 4
4 · BIO-RAD LABORATORIES, INC. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
BIO-RAD LABORATORIES, INC.BIO BIO.B
EVRAN SEDAT
EVP, Global Supply Chain
Transactions
- Tax Payment
Bio-Rad A Common Stock
2025-09-06$295.43/sh−277$81,834→ 1,523.847 total - Exercise/Conversion
Bio-Rad A Common Stock
2025-09-06+864→ 1,800.847 total - Award
Restricted Stock Units
2025-09-05+4,110→ 4,110 totalExercise: $0.00→ Bio-Rad A Common Stock (4,110 underlying) - Exercise/Conversion
Restricted Stock Units
2025-09-06−864→ 2,592 totalExercise: $0.00→ Bio-Rad A Common Stock (864 underlying)
Footnotes (4)
- [F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
- [F2]Includes 56.9880 and 26.7190 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2025 and 06/30/2025, respectively.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- [F4]The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.